Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

Astrazeneca plc is investing heavily in China, signing two R&D deals, worth up to about $8 billion in up-front payments and ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

Beijing assures US and other foreign business leaders that it will continue to open its market to investments and ...

Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...

Philanthropies, especially from venture-minded or justice-driven donors, could step in where policy has stalled. By funding ...

Beijing pledged to expand market access and attract greater foreign investment as top executives from Apple, Pfizer, FedEx ...

China reassured executives from American and European firms, including Apple, Qualcomm, Mastercard, Pfizer and AstraZeneca, ...

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

China is ready for “unexpected shocks”, premier Li Qiang said China told a gathering of foreign CEOs including Tim Cook of Apple (AAPL) and ...

The new centre will focus on early-stage research and clinical development, supported by data science and AI labs.

Chinese Vice Premier He Lifeng has reassured foreign business leaders that Beijing will continue to open up its market and ...